{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:43:31Z","timestamp":1766511811788,"version":"3.48.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2023YFC2308102"],"award-info":[{"award-number":["2023YFC2308102"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cca.2025.120661","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T22:31:04Z","timestamp":1760653864000},"page":"120661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early serum PreS1 levels are predictive of HBsAg loss in interferon-alpha treated children with HBeAg-positive chronic hepatitis B"],"prefix":"10.1016","volume":"579","author":[{"given":"Peiyao","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuchuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinjie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanwei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cca.2025.120661_bb0005","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S2468-1253(19)30042-1","article-title":"Hepatitis B virus infection in children and adolescents","volume":"4","author":"Indolfi","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.cca.2025.120661_bb0010","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/jgh.12550","article-title":"Management of chronic hepatitis B in children: an unresolved issue","volume":"29","author":"Della Corte","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"9454","key":"10.1016\/j.cca.2025.120661_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(05)17701-0","article-title":"Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial","volume":"365","author":"Janssen","year":"2005","journal-title":"Lancet"},{"issue":"10381","key":"10.1016\/j.cca.2025.120661_bb0020","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet (London, England)"},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2025.120661_bb0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/jvh.13154","article-title":"Long-term efficacy and safety of peginterferon in the treatment of children with HBeAg-positive chronic hepatitis B","volume":"26","author":"Liu","year":"2019","journal-title":"J. Viral Hepat."},{"issue":"2","key":"10.1016\/j.cca.2025.120661_bb0030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12072-023-10631-9","article-title":"Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B","volume":"18","author":"Zhang","year":"2024","journal-title":"Hepatol. Int."},{"issue":"1","key":"10.1016\/j.cca.2025.120661_bb0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/01.mpg.0000243439.47334.4e","article-title":"Long-term therapeutic efficacy of lamivudine compared with interferon-alpha in children with chronic hepatitis B: the younger the better","volume":"44","author":"Choe","year":"2007","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2025.120661_bb0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jvh.13165","article-title":"Interferon alpha treatment leads to a high rate of hepatitis B surface antigen seroconversion in Chinese children with chronic hepatitis B","volume":"26","author":"Fan","year":"2019","journal-title":"J. Viral Hepat."},{"issue":"3","key":"10.1016\/j.cca.2025.120661_bb0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.14218\/JCTH.2021.00142","article-title":"Clinical predictors of functional cure in children 1-6 years-old with chronic hepatitis B","volume":"10","author":"Pan","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"10","key":"10.1016\/j.cca.2025.120661_bb0050","first-page":"738","article-title":"A retrospective study on HBsAg clearance rate after antiviral therapy in children with HBeAg-positive chronic hepatitis B aged 1-7 years","volume":"24","author":"Zhu","year":"2016","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"1","key":"10.1016\/j.cca.2025.120661_bb0055","first-page":"59","article-title":"Analysis of prognostic factors in therapeutic effect to interferon alpha in children with HBeAg positive chronic hepatitis B","volume":"27","author":"Yan","year":"2019","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"4","key":"10.1016\/j.cca.2025.120661_bb0060","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/hep.29239","article-title":"Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice","volume":"66","author":"Bian","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cca.2025.120661_bb0065","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/liv.14298","article-title":"Quantitation of large, middle and small hepatitis B surface proteins in HBeAg-positive patients treated with peginterferon alfa-2a","volume":"40","author":"Rinker","year":"2020","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.cca.2025.120661_bb0070","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcv.2013.04.003","article-title":"Early serum hepatitis B virus large surface protein level: a stronger predictor of virological response to peginterferon alfa-2a than that to entecavir in HBeAg-positive patients with chronic hepatitis B","volume":"57","author":"Zhu","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.cca.2025.120661_bb0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cca.2018.02.015","article-title":"Prediction value of serum HBV large surface protein in different phases of HBV infection and virological response of chronic hepatitis B patients","volume":"481","author":"Liu","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"14\u201315","key":"10.1016\/j.cca.2025.120661_bb0080","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.clinbiochem.2011.07.002","article-title":"Hepatitis B virus large surface protein in serum as a candidate biomarker for evaluating hepatitis B virus infection","volume":"44","author":"Wang","year":"2011","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.cca.2025.120661_bb0085","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhep.2020.08.039","article-title":"Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B","volume":"74","author":"Pfefferkorn","year":"2021","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.cca.2025.120661_bb0090","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cca.2025.120661_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol. Int."},{"issue":"1\u20132","key":"10.1016\/j.cca.2025.120661_bb0100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jviromet.2010.04.029","article-title":"A novel immunoassay for PreS1 and\/or core-related antigens for detection of HBsAg variants","volume":"168","author":"Yuan","year":"2010","journal-title":"J. Virol. Methods"},{"issue":"6","key":"10.1016\/j.cca.2025.120661_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102369","article-title":"A retrospective study to determine the correlation among HBV PreS1 antigen, HBV e antigen, alanine aminotransferase, and HBV DNA","volume":"48","author":"Du","year":"2024","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"2","key":"10.1016\/j.cca.2025.120661_bb0110","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/15321819.2011.609576","article-title":"Detection of hepatitis B virus PreS1 antigen using a time-resolved fluoroimmunoassay","volume":"33","author":"Hu","year":"2012","journal-title":"J. Immunoass. Immunochem."},{"issue":"3","key":"10.1016\/j.cca.2025.120661_bb0115","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","article-title":"Classification of chronic viral hepatitis: a need for reassessment","volume":"13","author":"Scheuer","year":"1991","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.cca.2025.120661_bb0120","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/jvi.52.2.396-402.1984","article-title":"Large surface proteins of hepatitis B virus containing the pre-s sequence","volume":"52","author":"Heermann","year":"1984","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.cca.2025.120661_bb0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0033-1345717","article-title":"The molecular virology of hepatitis B virus","volume":"33","author":"Glebe","year":"2013","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"10.1016\/j.cca.2025.120661_bb0130","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1172\/JCI114299","article-title":"The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man","volume":"84","author":"Ferrari","year":"1989","journal-title":"J. Clin. Invest."},{"issue":"14","key":"10.1016\/j.cca.2025.120661_bb0135","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3748\/wjg.v11.i14.2088","article-title":"Identification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteins","volume":"11","author":"Hu","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cca.2025.120661_bb0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00430-014-0374-x","article-title":"Enhanced immune response to hepatitis B vaccination through immunization with a pre-S1\/pre-S2\/S vaccine","volume":"204","author":"Shouval","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"issue":"9","key":"10.1016\/j.cca.2025.120661_bb0145","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/jvh.13557","article-title":"Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patients","volume":"28","author":"Nishida","year":"2021","journal-title":"J. Viral Hepat."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125005406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125005406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T17:39:33Z","timestamp":1766511573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125005406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":29,"alternative-id":["S0009898125005406"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120661","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early serum PreS1 levels are predictive of HBsAg loss in interferon-alpha treated children with HBeAg-positive chronic hepatitis B","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120661"}}